Filing Details
- Accession Number:
- 0001567619-22-005913
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-03-01 18:53:31
- Reporting Period:
- 2022-02-28
- Accepted Time:
- 2022-03-01 18:53:31
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1829802 | Sensei Biotherapeutics Inc. | SNSE | () | DE |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1797409 | Cambrian Biopharma Inc | 19 Morris Avenue Brooklyn Navy Yard, Building 128 Brooklyn NY 11205 | No | No | Yes | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2022-02-28 | 42 | $3.60 | 5,228,328 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2022-03-01 | 2,458 | $3.60 | 5,230,786 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct | |
| No | 4 | P | Direct |
Footnotes
- These shares are held by Cambrian Biopharma, Inc., a Delaware corporation ("Cambrian"). The Chief Executive Officer of Cambrian, James Peyer, may direct the voting and disposition of the shares held by Cambrian, subject in certain instances to the approval of Cambrian's Board of Directors. Mr. Peyer disclaims beneficial ownership of such shares.
Billionaire Hedge Funds
